Lawmakers Probe FDA Over Handling Of Cordis Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
The House Energy and Commerce Committee sent letters to FDA and Johnson & Johnson Aug. 13 requesting documents as part of an inquiry into FDA's Office of Regulatory Affairs
You may also be interested in...
Retiring Rep. Dingell’s Health Policy Legacy Includes Fierce Oversight Of Device Center
A powerful former Chairman of the House Energy and Commerce Committee, Dingell has been not only a major player in the health care reform fight, but also a vigorous prober of FDA, launching investigations with lasting effects on the device center. The longest-serving member of the House announced his plans to retire at the end of this congressional term.
Retiring Rep. Dingell’s Health Policy Legacy Included Fierce Oversight Of Device Center
A powerful former Chairman of the House Energy and Commerce Committee, Dingell has not been only a major player in the health care reform fight, but also a vigorous prober of FDA, launching investigations with lasting effects on the device center. The longest-serving member of the House announced his plans to retire at the end of this congressional term.
Patients Deserve More Information On Potentially Faulty Devices – Maisel
A leading expert on medical device safety wants Congress to compel FDA and manufacturers to provide more consumer protections for patients with implanted devices